Screening compound: InChI=1S/C21H11ClN2O4S/c22-14-7-5-11(20(26)27)9-13(14)17-8-6-12(28-17)10-18-19(25)24-16-4-2-1-3-15(16)23-21(24)29-18/h1-10H,(H,26,27)

Screening compound: InChI=1S/C21H11ClN2O4S/c22-14-7-5-11(20(26)27)9-13(14)17-8-6-12(28-17)10-18-19(25)24-16-4-2-1-3-15(16)23-21(24)29-18/h1-10H,(H,26,27)
Screening compound: InChI=1S/C21H11ClN2O4S/c22-14-7-5-11(20(26)27)9-13(14)17-8-6-12(28-17)10-18-19(25)24-16-4-2-1-3-15(16)23-21(24)29-18/h1-10H,(H,26,27) alternative view

Chemical Structure Depiction of ChemDiv screening compound
InChI=1S/C21H11ClN2O4S/c22-14-7-5-11(20(26)27)9-13(14)17-8-6-12(28-17)10-18-19(25)24-16-4-2-1-3-15(16)23-21(24)29-18/h1-10H,(H,26,27)

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

4919-0190

Molecular Formula

C21H11ClN2O4S (C21 H11 ClN2 O4 S)

Compound Name

4-chloro-3-(5-{[3-oxo[1,3]thiazolo[3,2-a][1,3]benzimidazol-2(3H)-yliden]methyl}-2-furyl)benzoic acid

IUPAC name

4-chloro-3-(5-{[(4E)-3-oxo-5-thia-27-diazatricyclo[6.4.0.0^{26}]dodeca-1(12)6810-tetraen-4-ylidene]methyl}furan-2-yl)benzoic acid

SMILES

OC(c(cc1)cc(-c2ccc(/C=C3/Sc4nc(cccc5)c5n4C3=O)o2)c1Cl)=O

InChI

InChI=1S/C21H11ClN2O4S/c22-14-7-5-11(20(26)27)9-13(14)17-8-6-12(28-17)10-18-19(25)24-16-4-2-1-3-15(16)23-21(24)29-18/h1-10H,(H,26,27)

InChI Key

GPZCFDMVIYKQOP-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14710263

InChI=1S/C21H11ClN2O4S/c22-14-7-5-11(20(26)27)9-13(14)17-8-6-12(28-17)10-18-19(25)24-16-4-2-1-3-15(16)23-21(24)29-18/h1-10H,(H,26,27) in Drug Discovery

Included in Screening Libraries

DGK Inhibitors Library (10558 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Hemic and lymphatic
  • Skin
  • Metabolic
  • Immune system
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Kinases
  • Phosphatases

References: we are preparing a list of scientific research reports with InChI=1S/C21H11ClN2O4S/c22-14-7-5-11(20(26)27)9-13(14)17-8-6-12(28-17)10-18-19(25)24-16-4-2-1-3-15(16)23-21(24)29-18/h1-10H,(H,26,27) chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound InChI=1S/C21H11ClN2O4S/c22-14-7-5-11(20(26)27)9-13(14)17-8-6-12(28-17)10-18-19(25)24-16-4-2-1-3-15(16)23-21(24)29-18/h1-10H,(H,26,27)?
Check Price and Availability of InChI=1S/C21H11ClN2O4S/c22-14-7-5-11(20(26)27)9-13(14)17-8-6-12(28-17)10-18-19(25)24-16-4-2-1-3-15(16)23-21(24)29-18/h1-10H,(H,26,27), then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of InChI=1S/C21H11ClN2O4S/c22-14-7-5-11(20(26)27)9-13(14)17-8-6-12(28-17)10-18-19(25)24-16-4-2-1-3-15(16)23-21(24)29-18/h1-10H,(H,26,27) you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for InChI=1S/C21H11ClN2O4S/c22-14-7-5-11(20(26)27)9-13(14)17-8-6-12(28-17)10-18-19(25)24-16-4-2-1-3-15(16)23-21(24)29-18/h1-10H,(H,26,27)
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for InChI=1S/C21H11ClN2O4S/c22-14-7-5-11(20(26)27)9-13(14)17-8-6-12(28-17)10-18-19(25)24-16-4-2-1-3-15(16)23-21(24)29-18/h1-10H,(H,26,27)
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of InChI=1S/C21H11ClN2O4S/c22-14-7-5-11(20(26)27)9-13(14)17-8-6-12(28-17)10-18-19(25)24-16-4-2-1-3-15(16)23-21(24)29-18/h1-10H,(H,26,27) available by request